Trends in Molecular Medicine APC and Open Access: Cell Press Review Journal at $6,000-$7,000

Trends in Molecular Medicine isn't a standard review journal. It sits within the "Trends" family at Cell Press, alongside Trends in Genetics, Trends in Cell Biology, Trends in Immunology, and others. The "Trends" brand carries a specific editorial philosophy:

• Forward-looking synthesis: Articles should identify where a field is heading, not just summarize where it's been.
• Molecular mechanisms of disease: The journal bridges molecular biology and clinical medicine.
• Accessible writing: Trends journals aim for readability across a broad biomedical audience, not just specialists.
• Visual emphasis: Graphical abstracts and high-quality schematic figures are expected for every article.

The journal publishes several article types:

• Reviews: Full-length synthesis articles (4,000-6,000 words) covering molecular mechanisms of disease, therapeutic approaches, or diagnostic advances.
• Opinions: Shorter thought pieces (2,000-3,000 words) presenting a specific viewpoint on a controversial or emerging topic.
• Forum pieces: Brief commentary on recent developments.
• Spotlights: Very short highlights of notable recent papers.

Trends in Molecular Medicine published approximately 100-150 articles in 2024. Its impact factor of roughly 12 (2024 JCR) reflects the high citation rates that well-crafted review articles attract. The journal is selective, and most content is either commissioned by the editors or results from successful presubmission proposals.

Unlike Nature Reviews Cancer, which is almost exclusively invited, Trends in Molecular Medicine has a more open editorial model:

The presubmission inquiry process is the standard path for unsolicited contributions. Send a one-page outline describing the topic, the angle, key conclusions, and why the field needs this review now. The editors respond within 2-4 weeks. If they're interested, they'll invite a full submission. If the topic overlaps with a commissioned piece or doesn't fit the journal's current priorities, they'll decline quickly.

Success rates for unsolicited proposals are estimated at 10-20%. The editors have their own editorial calendar and topic priorities. Proposals that identify a genuinely new angle on a hot topic, rather than rehashing established ground, have the best chance.

This is the central financial issue with Trends in Molecular Medicine. As a Cell Press journal, it falls into the same category as Cancer Cell, Cell, Immunity, and other premium Elsevier titles: excluded from most Elsevier Read & Publish agreements.

A small number of institutions, notably the UC system, have negotiated expanded Elsevier deals that include Cell Press coverage. But this remains the exception. If you're at a European or US university with an Elsevier agreement, don't assume it covers Trends in Molecular Medicine. Ask your library specifically about Cell Press inclusion.

Cell Press/Elsevier's waiver framework:

• Geographical pricing (GPOA): Elsevier's system calculates a reduced APC based on the corresponding author's country and institution. Discounts range from 25% to 100%.
• Hardship waivers: Case-by-case consideration after acceptance. Contact the Cell Press editorial office.
• No society affiliation discounts: Unlike AACR journals, which offer member discounts, Cell Press doesn't have society membership-based reductions.

The waiver system is less transparent than Springer Nature's Research4Life framework. GPOA discounts are calculated automatically during the payment process, but the exact discount isn't always clear upfront. Authors from eligible countries should proceed through the payment portal to see their personalized APC before making a decision.

Review articles present a special case for funder mandates. Many OA policies specifically target funded research, and a review article may not directly report on funded research. If your review synthesizes your funder's research program, the mandate likely applies. If it's a broader field synthesis, check your funder's specific policy on review articles.

For NIH-funded researchers, the green OA route is free: publish via subscription, deposit in PMC after a 12-month embargo. This works well for review articles, since a review published today will still be highly relevant 12 months from now when the PMC embargo lifts.

The editorial expectations differ from original research journals. Trends journals want:

• A clear narrative arc: Your review should tell a story, not just catalogue facts. Start with a question, build through evidence, and arrive at forward-looking conclusions.
• Visual communication: Every review needs a graphical abstract and at least 2-4 high-quality schematic figures. These aren't afterthoughts. The editors consider figures part of the editorial assessment.
• Accessible language: Write for a broad biomedical audience, not just your subfield. Minimize jargon, explain technical concepts, and provide context for specialist terminology.
• A point of view: Trends articles should have opinions. "The field needs more research" isn't a conclusion. Identify specific gaps, predict where discoveries will come from, and state what the field should prioritize.

These requirements mean that writing a Trends review is different from writing a review for a specialist journal. The investment in writing quality and figure preparation is higher, which translates into real time and cost.

• Tax: EU VAT adds 15-25% to the APC in many jurisdictions. A $6,500 APC becomes $7,500-$8,100 with VAT.
• Figure preparation: Professional schematic figures are expected for every review. Budget $300-$1,000 per figure. A typical review with 4-5 figures could cost $1,200-$5,000 in illustration expenses.
• Graphical abstract: Required for every article. If you don't create your own, professional preparation costs $200-$500.
• Writing time: A Trends review takes 2-4 months of dedicated writing effort for an experienced researcher. The opportunity cost is significant.
• No institutional coverage: For most researchers, the full APC comes from lab funds or grants. Budget accordingly.

After a successful presubmission inquiry and invitation to submit, the review timeline is typically:

• Full manuscript review: 3-6 weeks for first decision
• Revision: 1-2 rounds, 2-4 weeks each
• Total timeline: 2-4 months from full submission to acceptance

The process is generally efficient. Trends journals have well-organized editorial teams, and the peer review (usually 2 external reviewers) tends to be focused on accuracy, completeness, and narrative quality rather than demanding additional experiments.

For researchers considering Trends in Molecular Medicine:

1. Start with a presubmission inquiry. Don't write a full review speculatively. Send a one-page outline and wait for editorial feedback.
2. Check Cell Press coverage. Your Elsevier deal almost certainly doesn't cover it. Ask your library explicitly about Cell Press inclusion.
3. Budget for the APC plus figures. The combined cost of the APC ($6,000-$7,000) plus professional figure preparation ($1,200-$5,000) can reach $12,000.
4. Consider the subscription track. If no funder mandate requires OA, publishing behind the paywall is free. The subscriber base reaches most biomedical researchers.
5. Comparing with Nature Reviews journals? If the review scope fits a Nature Reviews title (Nature Reviews Molecular Cell Biology, Nature Reviews Drug Discovery, etc.) and your institution has Springer Nature R&P coverage, the Nature Reviews option may be free despite the higher listed APC.

A strong review article for Trends in Molecular Medicine needs to do more than summarize the literature. It needs to identify patterns, challenge assumptions, and point the field toward unanswered questions. Run a free readiness scan to get feedback on your manuscript's narrative structure and argumentation before submitting.

For the latest APC information and author guidelines, visit the Trends in Molecular Medicine author page.